Cycle XXXVI (2020/2021)
- Call for selection for admission to the PhD courses of the XXXVI Cycle – a.a. 2020/21 – D.R. n. 1021
- General informations – 2020/2021
DETAILS OF A.Y. 2020/2021 PH.D. PROGRAMME IN “Molecular and Translational Oncology and Innovative Medical Surgical Technologies”
|EDUCATIONAL OBJECTIVES||The aim of the Ph.D. is to train professionals with interdisciplinary skills in oncological research, autonomy in planning, execution and interpretation of experiments, formulation of research projects and writing of scientific articles.|
|Curriculum 1||Molecular Oncology.
Main objectives: Study of the molecular alterations involved in the onset, progression and dispersal of
|Curriculum 2||Biomedical, Systems and applied nanotechnologies Engineering.
Main objectives: Methods and technologies for the modelling, simulation, and control of biological systems, the elaboration of images aimed at the planning of therapeutic interventions, the planning of nanotechnologies based innovative biomedical devices.
|Curriculum 3||Medical translational oncology.
Main objectives: Innovative approaches for the development of high-selectivity diagnostic, therapeutic and/or pre-emptive strategies in medical oncology.
|Curriculum 4||Innovative technologies and therapies in urological, gynaecological surgery and in fertility
Main objectives: clinical research methodology applies to oncological pathologies relating to urology and gynaecology (primary prevention, precocious diagnosing and treatment) and to innovative fertility preservation therapies.
|Programme Duration||3 years|
|Coordinator|| Prof. Giovanni Cuda